Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 508869 | NSE: APOLLOHOSP

Apollo Hospitals Enterprise Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 2:53 am

Market Cap 1,04,268 Cr.
Current Price 7,252
High / Low 7,545/5,526
Stock P/E88.1
Book Value 522
Dividend Yield0.22 %
ROCE15.1 %
ROE13.3 %
Face Value 5.00
PEG Ratio8.07

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for

Competitors of

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
NG Industries Ltd 61.0 Cr. 182 230/13610.4 1241.92 %6.50 %5.63 % 10.0
Global Longlife Hospital and Research Ltd 32.0 Cr. 30.5 61.7/27.0 25.90.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 19.6 Cr. 19.0 29.0/17.04.82 19.20.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 111 Cr. 59.1 108/44.0 15.971.9 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 36.7 Cr. 6.79 10.3/6.230.89 2.670.00 %15.4 %24.1 % 10.0
Industry Average25,292.00 Cr771.7353.9289.623.18%12.34%12.42%9.12

All Competitor Stocks of

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales2,7602,8683,7603,7173,6393,5463,7964,2514,2644,3024,4184,8474,851
Expenses2,3702,4563,2443,1023,0523,0833,3173,6993,7803,8143,9094,2194,237
Operating Profit390412516615587463479552484488509628614
OPM %14%14%14%17%16%13%13%13%11%11%12%13%13%
Other Income21633198233416233520342629
Interest1019995959495939310095106111113
Depreciation125138141145149166148155153159167163167
Profit before tax185238599383367236254327266254270379363
Tax %28%28%16%30%34%59%-27%35%39%43%36%34%30%
Net Profit13417050126724397324213162146173249254
EPS in Rs9.3811.6734.0317.2415.886.2722.0614.1910.6810.0511.5916.2017.06

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales3,1483,7694,3575,1296,1507,2568,2439,61711,24710,56014,66316,61218,418
Expenses2,6313,1573,6814,3925,4656,5227,4428,5489,6569,42012,47414,54816,179
Operating Profit5176126767376847348011,0701,5911,1402,1892,0652,238
OPM %16%16%16%14%11%10%10%11%14%11%15%12%12%
Other Income223318479260242622210336875110
Interest89103119118180257295327533449379381426
Depreciation124142168212264314359396620573601615656
Profit before tax3263994074553322221713736602211,5781,1441,266
Tax %35%26%25%29%29%41%65%47%34%38%30%22%
Net Profit218303315335235131602004321371,108844822
EPS in Rs16.3121.8822.7724.4316.9915.888.4416.9632.7010.4673.4256.9754.90
Dividend Payout %25%25%25%24%35%38%59%35%18%29%16%26%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)38.99%3.96%6.35%-29.85%-44.26%-54.20%233.33%116.00%-68.29%708.76%-23.83%
Change in YoY Net Profit Growth (%)0.00%-35.03%2.39%-36.20%-14.40%-9.94%287.53%-117.33%-184.29%777.05%-732.59%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:16%
5 Years:15%
3 Years:22%
TTM:15%
Compounded Profit Growth
10 Years:11%
5 Years:34%
3 Years:109%
TTM:70%
Stock Price CAGR
10 Years:20%
5 Years:39%
3 Years:15%
1 Year:31%
Return on Equity
10 Years:9%
5 Years:12%
3 Years:14%
Last Year:13%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:42 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital70707070707070707272727272
Reserves2,6772,9073,1023,2623,2443,1823,2643,2704,5315,5516,1266,8647,429
Borrowings1,2131,3441,9922,8343,1253,4273,6733,5964,1604,0684,3325,3337,371
Other Liabilities8541,0291,2961,1951,6651,9172,1594,3542,6293,5703,8864,4744,676
Total Liabilities4,8145,3506,4597,3608,1038,5969,16611,28911,39213,26114,41616,74219,548
Fixed Assets2,3412,6813,2443,9974,5914,7734,9827,4326,7788,2968,5209,66410,201
CWIP403491533562347712822236234466108731,042
Investments5273223113524063524624341,3438165749861,012
Other Assets1,5431,8552,3722,4482,7592,7592,9013,1873,0374,1044,7125,2197,293
Total Assets4,8145,3506,4597,3608,1038,5969,16611,28911,39213,26114,41616,74219,548

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +4433734705976235379051,2931,2651,6961,3771,920
Cash from Investing Activity +-733-356-759-888-1,152-405-711-289-880-747-857-1,537
Cash from Financing Activity +373-63392330477-108-215-910-340-792-633-311
Net Cash Flow83-4610339-5224-209444158-11372

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow517.00611.00675.00736.00682.00731.00798.00-2.00-2.00-3.00-2.00-2.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days464443363837393346444948
Inventory Days434750494751464916211717
Days Payable535559665155566074798288
Cash Conversion Cycle3636341934332922-12-14-16-23
Working Capital Days1728302730251691213182
ROCE %13%12%12%9%8%7%10%14%8%17%14%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters29.82%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%
FIIs51.54%52.41%50.81%48.48%49.09%47.94%46.96%47.93%46.15%46.25%45.63%43.92%
DIIs12.28%12.17%12.93%15.64%15.28%16.56%17.76%17.02%18.59%18.87%19.55%21.13%
Government0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%
Public6.14%5.86%6.70%6.32%6.07%5.94%5.72%5.49%5.68%5.32%5.26%5.38%
No. of Shareholders98,45299,1351,26,2261,46,3201,35,9231,31,6361,31,9371,20,0301,31,5651,19,5781,30,6641,27,754

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Flexi Cap Fund - Regular Plan3,207,1664.282037.51,822,3472024-12-2075.99%
SBI Nifty 50 ETF1,822,3470.671157.731,822,3472024-12-200%
Axis ELSS Tax Saver Fund1,426,3572.7906.161,822,3472024-12-20-21.73%
Aditya Birla Sun Life Flexi Cap Fund950,0003.08603.531,822,3472024-12-20-47.87%
HDFC ELSS Tax Saver Fund750,0003.54476.471,822,3472024-12-20-58.84%
Nippon India Pharma Fund648,7955.98412.181,822,3472024-12-20-64.4%
HDFC Focused 30 Fund - Regular Plan625,0004.26397.061,822,3472024-12-20-65.7%
Axis Bluechip Fund622,0601.21395.191,822,3472024-12-20-65.86%
Axis Focused 25 Fund593,2702.72376.91,822,3472024-12-20-67.44%
UTI Nifty 50 ETF504,6460.67320.61,822,3472024-12-20-72.31%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue5.005.005.005.005.00
Basic EPS (Rs.)62.5056.9773.4210.7432.70
Diluted EPS (Rs.)62.5056.9773.4210.7432.70
Cash EPS (Rs.)111.54104.51118.3449.3175.75
Book Value[Excl.RevalReserv]/Share (Rs.)509.07454.19408.74333.96249.27
Book Value[Incl.RevalReserv]/Share (Rs.)509.07454.19408.74333.96249.27
Revenue From Operations / Share (Rs.)1325.401155.251019.65734.35807.96
PBDIT / Share (Rs.)173.64148.81157.3982.22115.96
PBIT / Share (Rs.)125.87106.02115.6242.3771.44
PBT / Share (Rs.)94.7579.53109.7415.3547.41
Net Profit / Share (Rs.)63.7761.7276.579.4631.24
NP After MI And SOA / Share (Rs.)62.4956.9673.4110.4632.67
PBDIT Margin (%)13.1012.8815.4311.1914.35
PBIT Margin (%)9.499.1711.335.768.84
PBT Margin (%)7.146.8810.762.085.86
Net Profit Margin (%)4.815.347.501.283.86
NP After MI And SOA Margin (%)4.714.937.191.424.04
Return on Networth / Equity (%)12.9513.2118.773.2613.62
Return on Capital Employeed (%)14.9713.7315.386.4911.04
Return On Assets (%)5.365.678.001.314.01
Long Term Debt / Equity (X)0.320.310.430.530.85
Total Debt / Equity (X)0.450.430.460.541.00
Asset Turnover Ratio (%)1.220.540.550.861.01
Current Ratio (X)1.131.301.731.791.13
Quick Ratio (X)1.031.191.551.660.81
Dividend Payout Ratio (NP) (%)24.0031.154.1325.4628.38
Dividend Payout Ratio (CP) (%)13.6017.792.635.2912.01
Earning Retention Ratio (%)76.0068.8595.8774.5471.62
Cash Earning Retention Ratio (%)86.4082.2197.3794.7187.99
Interest Coverage Ratio (X)5.565.625.982.633.03
Interest Coverage Ratio (Post Tax) (X)3.043.333.131.171.44
Enterprise Value (Cr.)93953.5264237.5766797.8843713.8018852.27
EV / Net Operating Revenue (X)4.933.874.564.141.68
EV / EBITDA (X)37.6330.0229.5136.9711.68
MarketCap / Net Operating Revenue (X)4.793.734.433.951.41
Retention Ratios (%)75.9968.8495.8674.5371.61
Price / BV (X)13.1710.0011.559.074.74
Price / Net Operating Revenue (X)4.793.734.433.951.41
EarningsYield0.010.010.010.000.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of December 21, 2024 is: 6,129.89

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 21, 2024, is Overvalued by 15.47% compared to the current share price 7,252.00

Intrinsic Value of as of December 21, 2024 is: 6,799.20

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 21, 2024, is Overvalued by 6.24% compared to the current share price 7,252.00

Last 5 Year EPS CAGR: 10.92%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of 18.92, which is a positive sign.
  2. The company has higher reserves (4,262.23 cr) compared to borrowings (3,574.46 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (8.77 cr) and profit (274.54 cr) over the years.
  1. The stock has a low average ROCE of 11.58%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 14.83, which may not be favorable.
  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
    1. Net Profit Margin: 4.81%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 14.97% (Industry Average ROCE: 12.34%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 12.95% (Industry Average ROE: 12.42%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 3.04
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.03
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 88.1 (Industry average Stock P/E: 53.92)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.45
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 6098.30 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesNo.19, Bishop Gardens, Chennai (Madras) Tamil Nadu 600028investor.relations@apollohospitals.com
https://www.apollohospitals.com
Management
NamePosition Held
Dr. Prathap C ReddyFounder & Executive Chairman
Mrs. Preetha ReddyExecutive Vice Chairperson
Mrs. Suneeta ReddyManaging Director
Mrs. Sangita ReddyJoint Managing Director
Dr. Som MittalIndependent Director
Mrs. V Kavitha DuttIndependent Director
Dr. Murali DoraiswamyIndependent Director
Mrs. Rama BijapurkarIndependent Director
Mr. Vinayak ChatterjeeIndependent Director
Mr. M B N RaoLead Independent Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 21 December 2024 is ₹6129.89, which is 15.47% lower than the current market price of ₹7,252.00. The stock has a market capitalization of 1,04,268 Cr. and recorded a high/low of 7,545/5,526 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹7,429 Cr and total liabilities of ₹19,548 Cr.

What is the Market Cap of ?

The Market Cap of is 1,04,268 Cr..

What is the current Stock Price of as on 21 December 2024?

The current stock price of as on 21 December 2024 is 7,252.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 7,545/5,526.

What is the Stock P/E of ?

The Stock P/E of is 88.1.

What is the Book Value of ?

The Book Value of is 522.

What is the Dividend Yield of ?

The Dividend Yield of is 0.22 %.

What is the ROCE of ?

The ROCE of is 15.1 %.

What is the ROE of ?

The ROE of is 13.3 %.

What is the Face Value of ?

The Face Value of is 5.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in . Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE